EUVIMEDEUVIMED entdecken
Crossref

Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis

Liam M Koehn iD, Joel R Steele iD, Ralf B Schittenhelm iD, Bradley J Turner, Joseph A Nicolazzo iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c01089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Liam M Koehn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Organic Anion Transporters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Bethlehem Griffiths Research Foundation, Stafford Fox Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is characterized by death and dysfunction of motor neurons that result in a rapidly progressing loss of motor function. While there are some data on alterations at the blood-brain barrier (BBB) in ALS and their potential impact on CNS trafficking of drugs, little is reported on the impact of this disease on the expression of drug-handling proteins in the small intestine and liver. This may impact the dosing of the many medicines that individuals with ALS are prescribed. In the present study, a proteomic evaluation was performed on small intestine and liver samples from postnatal day 120 SOD1G93A mice (a model of familial ALS that harbors a human mutant form of superoxide dismutase 1) and wild-type (WT) littermates (n = 7/genotype/sex). Untargeted, quantitative proteomics was undertaken using either label-based [tandem mass tag (TMT)] or label-free [data-independent acquisition (DIA)] acquisition strategies on high-resolution mass spectrometric instrumentation. Copper chaperone for superoxide dismutase (CCS) was significantly higher in SOD1G93A samples compared to the WT samples for both sexes and tissues, therefore representing a potential biomarker for ALS in this mouse model. Relative to WT mice, male SOD1G93A mice had significantly different proteins (Padj 1.2) in the small intestine (male 22, female 1) and liver (male 140, female 3). This included an up-regulation of intestinal transporters for dietary glucose [solute carrier (SLC) SLC5A1] and cholesterol (Niemann-Pick c1-like 1), as well as for several drugs (e.g., SLC15A1), in the male SOD1G93A mice. There was both an up-regulation (e.g., SLCO2A1) and down-regulation (ammonium transporter rh type b) of transporters in the male SOD1G93A liver. In addition, there was both an up-regulation (e.g., phosphoenolpyruvate carboxykinase) and down-regulation (e.g., carboxylesterase 1) of metabolizing enzymes in the male SOD1G93A liver. This proteomic data set identified male-specific changes to key small intestinal and hepatic transporters and metabolizing enzymes that may have important implications for the bioavailability of nutrients and drugs in individuals with ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisOrganic Anion TransportersAnimalsFemaleHumansMaleMiceDisease Models, AnimalLiverMice, TransgenicProteomicsSuperoxide DismutaseSuperoxide Dismutase-1

Stichwörter der Autor:innen

amyotrophic lateral sclerosislivermetabolizing enzymemotor neuron diseasesmall intestinetransporter

Substanzen

Organic Anion TransportersSLCO2A1 protein, humanSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1

Autor:innen und Institutionen

  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.
  • Monash Proteomics and Metabolomics Platform, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton 3800, Victoria, Australia.
  • The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3052, Victoria, Australia.

ORCID-Profile: Liam M Koehn, Joel R Steele, Ralf B Schittenhelm, Joseph A Nicolazzo

Förderung

  • Bethlehem Griffiths Research Foundation
  • Stafford Fox Medical Research Foundation

Zitieren

APA

Koehn, L. M., Steele, J. R., Schittenhelm, R. B., Turner, B. J., & Nicolazzo, J. A. (2024). Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01089

Vancouver

Koehn LM, Steele JR, Schittenhelm RB, Turner BJ, Nicolazzo JA. Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01089

BibTeX
@article{Koehn2024,
  author = {Koehn, Liam M and Steele, Joel R and Schittenhelm, Ralf B and Turner, Bradley J and Nicolazzo, Joseph A},
  title = {Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c01089}
}
Kostenlos starten →